Showing 20 of 173 recruiting trials for “squamous-cell-carcinoma-of-the-oropharynx”
Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma
Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma
Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC
👨⚕️ Song Zhao, The First Affiliated Hospital of Zhengzhou University📍 1 site📅 Started Jan 2022View details ↗
Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy
Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)
RecruitingNCT05126160 ↗
Immune Score Based Radiomics in Nasopharyngeal Carcinoma
👨⚕️ Xiaozhong Chen, Department of Radiation Oncology, Zhejiang Cancer Hospital📍 5 sites📅 Started Nov 2021View details ↗
ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma
RecruitingNCT05740995 ↗
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer
👨⚕️ Magnus Nilsson, MD, PhD, Karolinska University Hospital📍 12 sites📅 Started Nov 2020View details ↗
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
👨⚕️ Mary Feng, MD, University of California, San Francisco📍 2 sites📅 Started Aug 2020View details ↗
Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
👨⚕️ Jinquan Liu, M.D, Affiliated Cancer Hospital & Institute of Guangzhou Medical University📍 1 site📅 Started Aug 2020View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →